INCY · Forms 3, 4, 5
Insider trades at INCYTE CORP
2 insiders sold $14.7M of INCYTE CORP stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for INCYTE CORP (INCY) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Lee Heeson | EVP, Head of Incyte Intl | Tax withholding | 463 | $117.14 | $54K | Form 4 | |
| BAKER BROS. ADVISORS LP | Director | Award | 322 | Form 4 | |||
| BAKER BROS. ADVISORS LP | Director | Award | 322 | Form 4 | |||
| Paul J Clancy | Director | Award | 203 | $121.35 | $25K | Form 4 | |
| Edmund Harrigan | Director | Award | 206 | $121.35 | $25K | Form 4 | |
| David H Gardner | EVP, Chief Strategy Officer | Tax withholding | 920 | $126.93 | $117K | Form 4 | |
| Pablo J Cagnoni | President, Global Head of R&D | Option exercise | 2,957 | $61.76 | $183K | Form 4 | |
| Pablo J Cagnoni | President, Global Head of R&D | Option exercise | 4,551 | $61.18 | $278K | Form 4 | |
| Pablo J Cagnoni | President, Global Head of R&D | Option exercise | 6,477 | $64.25 | $416K | Form 4 | |
| Pablo J Cagnoni | President, Global Head of R&D | Option exercise | 9,233 | $71.93 | $664K | Form 4 | |
| Pablo J Cagnoni | President, Global Head of R&D | Sell | 9,233 | $120.50 | $1.1M | Form 4 | |
| Pablo J Cagnoni | President, Global Head of R&D | Sell | 13,985 | $120.49 | $1.7M | Form 4 | |
| Ramitpal K Basi | EVP, Human Resources | Tax withholding | 504 | $129.72 | $65K | Form 4 | |
| Pablo J Cagnoni | President, Global Head of R&D | Sell | 10,801 | $125.56 | $1.4M | Form 4 | |
| Pablo J Cagnoni | President, Global Head of R&D | Sell | 10,803 | $120.04 | $1.3M | Form 4 | |
| Pablo J Cagnoni | President, Global Head of R&D | Sell | 10,640 | $122.69 | $1.3M | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Option exercise | 2,207 | $106.47 | $235K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Sell | 2,207 | $123.99 | $274K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Option exercise | 6,055 | $105.43 | $638K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Sell | 6,055 | $120.43 | $729K | Form 4 | |
| Pablo J Cagnoni | President, Global Head of R&D | Sell | 15,888 | $119.70 | $1.9M | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Option exercise | 2,918 | $61.18 | $179K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Option exercise | 2,284 | $64.25 | $147K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Option exercise | 2,709 | $61.76 | $167K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Option exercise | 3,148 | $68.62 | $216K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Option exercise | 2,072 | $71.93 | $149K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Option exercise | 9,459 | $72.27 | $684K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Option exercise | 2,623 | $74.78 | $196K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Option exercise | 2,864 | $77.67 | $222K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Option exercise | 1,643 | $80.50 | $132K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Option exercise | 3,023 | $83.20 | $252K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Option exercise | 2,623 | $83.58 | $219K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Option exercise | 1,642 | $85.01 | $140K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Option exercise | 2,293 | $90.56 | $208K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Option exercise | 85 | $106.47 | $9K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Option exercise | 326 | $105.43 | $34K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Sell | 14,661 | $119.46 | $1.8M | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Sell | 5,332 | $119.42 | $637K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Sell | 2,187 | $119.47 | $261K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Sell | 6,171 | $119.43 | $737K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Sell | 4,695 | $119.39 | $561K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Sell | 2,864 | $119.40 | $342K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Sell | 1,643 | $119.51 | $196K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Sell | 1,642 | $119.38 | $196K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Sell | 85 | $122.19 | $10K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Sell | 326 | $121.69 | $40K | Form 4 | |
| Patrick A Mayes | EVP & Chief Scientific Officer | Sell | 2,293 | $119.41 | $274K | Form 4 | |
| Michael James Morrissey | EVP, Head of Tech. Operations | Options or other derivatives | Form 4 | ||||
| Lee Heeson | EVP, Head of Incyte Intl | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.